Researchers discover a new way of reducing disease toxicity in ALS which slows the dysfunction of neurons.
Microglia plays crucial roles both in healthy and diseased brains, a new study reports.
Researchers create neurons from the skin cells of ALS patients in order to "treat" a gene defect in a dish.
Using neurons created from iPS cells derived from people with ALS, researchers develop a new drug which appears to halt the impact of the genetic mutations in some forms of ALS and dementia.
Axon pruning becomes reactivated in neurodegenerative diseases, a new study finds.
New research could help find a solution to slowing down the progression of motor neuron disease.
Researchers find the amino acid, BMAA, can be inserted into neuroproteins. This causes them to misfold and aggregate. BMAA has been detected in the brains of those with ALS.
Researchers have identified a possible molecular pathway which could be the of cause a number of neurodegenerative diseases, including Huntington's disease and ALS.
Researchers discover link between an inability for neurons to repair DNA and neurodegenerative diseases such as ALS.
By reducing the expression of the SOD1 gene, ALS onset and progression is slowed, a new study suggests.
Researchers discover four new potential biomarkers which characterize non-genetic ALS. The findings could provide new directions for diagnostics and treatment of ALS.
Researchers discover a new class of experimental drug like small molecules show promise in targeting a brain enzyme to prevent early memory loss in Alzheimer's disease.
